Growing community of inventors

White River Junction, VT, United States of America

Mark R Spaller

Average Co-Inventor Count = 3.98

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 11

Mark R SpallerRandolph J Noelle (3 patents)Mark R SpallerElizabeth Nowak (3 patents)Mark R SpallerLi Wang (3 patents)Mark R SpallerIsabelle Lemercier (3 patents)Mark R SpallerSabrina Ceeraz (3 patents)Mark R SpallerJanet Lines (3 patents)Mark R SpallerJohn Marshall (2 patents)Mark R SpallerDebabrata Mukhopadhyay (2 patents)Mark R SpallerDennis J Goebel (2 patents)Mark R SpallerPriyabrata Mukherjee (2 patents)Mark R SpallerDean R Madden (1 patent)Mark R SpallerNicholas P Gill (1 patent)Mark R SpallerCarrie Ann Davison (1 patent)Mark R SpallerMark R Spaller (8 patents)Randolph J NoelleRandolph J Noelle (66 patents)Elizabeth NowakElizabeth Nowak (18 patents)Li WangLi Wang (9 patents)Isabelle LemercierIsabelle Lemercier (8 patents)Sabrina CeerazSabrina Ceeraz (6 patents)Janet LinesJanet Lines (6 patents)John MarshallJohn Marshall (66 patents)Debabrata MukhopadhyayDebabrata Mukhopadhyay (6 patents)Dennis J GoebelDennis J Goebel (3 patents)Priyabrata MukherjeePriyabrata Mukherjee (2 patents)Dean R MaddenDean R Madden (10 patents)Nicholas P GillNicholas P Gill (1 patent)Carrie Ann DavisonCarrie Ann Davison (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Dartmouth College (5 from 664 patents)

2. King's College London (3 from 175 patents)

3. Mayo Foundation for Medical Education and Research (2 from 1,746 patents)

4. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,446 patents)

5. Brown University (1 from 469 patents)

6. Darmouth College (1 from 7 patents)

7. Spaller, Mark (0 patent)


8 patents:

1. 12064463 - Vista antagonist and methods of use

2. 11752189 - Vista antagonist and methods of use

3. 10933115 - VISTA antagonist and methods of use

4. 10744180 - Therapy and kit for the prevention and treatment of cystic fibrosis

5. 10046024 - Cyclic-GluR6 analogs, methods of treatment and use

6. 9403876 - Cyclic-GluR6 analogs, methods of treatment and use

7. 9163063 - Peptides and nanoparticles for therapeutic and diagnostic applications

8. 8658601 - Peptides and nanoparticles for therapeutic and diagnostic applications

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…